Exchange: TSX·Updated 03:49 PM EDT

RVX.TSX Resverlogix Corp.

$0.10
$0.005
(5.26%)
Today
Mkt Cap$34.43M
Vol1,600.00

About RVX.TSX

Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. It develops Apabetalone for diabetes mellitus, chronic kidney, peripheral artery, Orphan, and Alzheimer's diseases. The company was founded by Donald J. McCaffrey and Norman C. W. Wong on August 17, 2000 and is headquartered in Calgary, Canada.
50

Neutral Sentiment

How do you feel about RVX.TSX?

Advertisement|Remove ads.